Prexion receives FDA approval for Eclipse 3D Cone Beam Computed Tomography Dental Scanner

NewsGuard 100/100 Score

The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner --Today, Prexion, Inc. announced FDA approval of the The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner.

"The exciting new 3D Eclipse highlights 2-in-1 and 3-in-1 multi-functionality, featuring dedicated 2D Digital Panoramic and Cephalometric options as well as maintaining industry leading CBCT 3D diagnostic clarity Prexion is famous for. The 3D Eclipse offers a new "Wide Mode" feature, enabling the clinician to capture full upper and lower dental arches, including the entire 3rd Molar region" said Takashi Funai , CEO at Prexion, Inc.


The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner Availability

The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner is a new product driven by customer feedback and is part of Prexion, Inc.'s commitment to deliver the highest 3D diagnostic clarity yet provide dedicated 2D digital radiographic and 3D CBCT modalities. The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner is available for demonstration at www.prexion.com or by calling 1-855-PREXION.

SOURCE Prexion, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Comparing two plasma p-tau217 assays for Alzheimer's detection and monitoring